Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUkrproduct Regulatory News (UKR)

Share Price Information for Ukrproduct (UKR)

Share Price is delayed by 15 minutes
Get Live Data
6.975    0.00 (0.00%)
Bid:
6.00
Ask:
7.95
Spread: 1.95 (32.50%)
Market Cap: £2.77m
UKR Live PriceLast checked at - London Stock Exchange

Intraday Ukrproduct Share Chart

NOMAD UPDATE

18 Oct 2017 16:27

RNS Number : 9967T
Ukrproduct Group Ltd
18 October 2017
 

18 October 2017

 

Ukrproduct Group Ltd

 

NOMAD UPDATE

 

As previously disclosed, the Company's Nominated Adviser will have their Nominated Adviser status rescinded effective at 7am 19 October 2017. At that point the Company's shares will be suspended from trading on AIM, pursuant to AIM Rule 1.

 

The Company has not yet appointed a replacement Nominated Adviser and accordingly, the trading of the shares of the company on the AIM will be suspended.

 

Pursuant to Rule 1 of the AIM Rules, the Company has one month to appoint a replacement Nominated Adviser or else the admission of its AIM securities will be cancelled.

 

The Company's board are continuing with its efforts to secure a new Nominated Adviser.

 

For further information contact:

 

Ukrproduct Group Ltd Tel: +380 44 232 9602

Jack Rowell, Non-Executive Chairman www.ukrproduct.com

Alexander Slipchuk, Chief Executive Officer

 

ZAI Corporate Finance Ltd Tel: +44 20 7060 2220

Nominated Adviser and Broker www.zaicf.com

John Treacy

 

 

This announcement contains information which was previously inside information for the purposes of Article 7 of the Market Abuse Regulation EU Regulation 596/2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKFDBPBDDQKD
Date   Source Headline
18th Oct 20174:27 pmRNSNOMAD UPDATE
11th Oct 201710:58 amRNSRemoval of Nomad Status
10th Oct 20176:15 pmRNSNomad Register Change - ZAI Corporate Finance Ltd
28th Sep 20174:46 pmRNSInterim results 2017
11th Sep 20178:41 amRNSLoan Agreement
26th Jul 20174:25 pmRNSCorrective Statement
20th Jul 20175:51 pmRNSResult of AGM
29th Jun 20174:24 pmRNSFinal Results
26th Jun 20176:02 pmRNSAmendment to OTP Bank Loan Agreement
26th Jun 20177:00 amRNSFurther re Loan Agreement
9th Jun 20177:00 amRNSAmended loan agreement
27th Jan 20174:40 pmRNSSecond Price Monitoring Extn
27th Jan 20174:35 pmRNSPrice Monitoring Extension
27th Jan 201712:59 pmRNSTrading update
27th Oct 20161:27 pmRNSStatement re EBRD Loan
30th Sep 201612:35 pmRNSHalf-year Report
8th Sep 201612:25 pmRNSTrading Update
25th Jul 20165:28 pmRNSResult of AGM
30th Jun 201612:26 pmRNSFinal Results
30th Jun 20167:00 amRNSEBRD loan amendment
15th Jun 20162:48 pmRNSEBRD Loan
9th May 201610:15 amRNSBoard Changes
14th Mar 20167:00 amRNSUKRPRODUCT GROUP and EBRD Loan
19th Jan 20164:40 pmRNSSecond Price Monitoring Extn
19th Jan 20164:35 pmRNSPrice Monitoring Extension
15th Jan 201611:30 amRNSTRADING UPDATE
15th Dec 20157:00 amRNSEBRD Loan
30th Sep 20157:00 amRNSHalf Yearly Report
11th Sep 20154:58 pmRNSStatement re: EBRD Loan
21st Aug 20159:08 amRNSTRADING UPDATE
24th Jul 20155:02 pmRNSResult of AGM
30th Jun 20154:35 pmRNSPosting of Annual Report and Notice of AGM
24th Jun 20157:00 amRNSFinal Results
11th Jun 201511:24 amRNSEBRD Loan
2nd Apr 20155:20 pmRNSStatement re EBRD Loan
31st Mar 20157:00 amRNSChange of Adviser
2nd Feb 201510:47 amRNSADMISSION TO TRADING ON UKRAINIAN STOCK MARKET
23rd Dec 20144:21 pmRNSTrading Update
18th Dec 201410:52 amRNSDirector's Dealing
24th Nov 20147:00 amRNSDirectors' Dealings
5th Nov 20144:13 pmRNSDirector/PDMR Shareholding
7th Oct 201410:42 amRNSSuccessful Completion of Compliance Audit
24th Sep 201411:41 amRNSUnaudited Interim Financial Results
1st Aug 20149:45 amRNSTrading Update
25th Jun 20145:13 pmRNSResult of AGM
13th Jun 201410:58 amRNSPosting of Annual Report
29th May 20143:35 pmRNSNotice of AGM
30th Apr 20143:22 pmRNSFinal Results
11th Mar 20144:40 pmRNSSecond Price Monitoring Extn
11th Mar 20144:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.